Point72 Hong Kong’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,325
Closed -$62.3K 689
2024
Q1
$62.3K Sell
3,325
-7,609
-70% -$176K ﹤0.01% 447
2023
Q4
$237K Buy
+10,934
New +$217K 0.01% 419
2022
Q3
Sell
-9,927
Closed -$321K 2363
2022
Q2
$321K Buy
9,927
+1,176
+13% +$39.4K 0.01% 845
2022
Q1
$290K Buy
8,751
+4,521
+107% +$170K 0.01% 850
2021
Q4
$180K Sell
4,230
-448
-10% -$18.8K 0.01% 1036
2021
Q3
$207K Buy
+4,678
New +$215K 0.01% 1159
2020
Q2
Sell
-412
Closed -$12K 1391
2020
Q1
$12K Sell
412
-988
-71% -$57.2K 0.01% 647
2019
Q4
$101K Buy
1,400
+350
+33% +$43.1K 0.02% 513
2019
Q3
$147K Buy
1,050
+808
+334% +$135K 0.04% 364
2019
Q2
$44K Buy
+242
New +$41.3K 0.01% 653
2018
Q4
Sell
-603
Closed -$85K 1163
2018
Q3
$85K Buy
603
+416
+222% +$64.2K 0.03% 371
2018
Q2
$29K Buy
+187
New +$29.4K 0.01% 528
2017
Q4
Sell
-67
Closed -$4K 1058
2017
Q3
$4K Buy
+67
New +$5.26K ﹤0.01% 596
2017
Q2
Sell
-613
Closed -$44K 1006
2017
Q1
$44K Buy
613
+606
+8,657% +$35.5K 0.06% 262
2016
Q4
$0 Buy
+7
New +$330 ﹤0.01% 1020

Other funds holding SAGE